Recital 2, Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…

In forcecited 1×

Such studies may not have been undertaken for use in the paediatric population and many of the medicinal products currently used to treat the paediatric population have not been studied or authorised for such use. Market forces alone have proven insufficient to stimulate adequate research into, and the development and authorisation of, medicinal products for the paediatric population.

  • Judgment of the General Court (Third Chamber) of 14 December 2011. Nycomed Danmark ApS v European Medicines Agency (EMA).Decision

    Recital 2 in the preamble to Regulation No 1901/2006 states that market forces alone have proven insufficient to stimulate adequate research into, and the development and authorisation of, medicinal products for the paediatric population.

    14 Dec 2011 · 62009TJ0052